Drug info

Tirzepatide

GIP and GLP-1 receptor agonist Prescription only

Copies two natural gut hormones that control blood sugar and appetite. Used for type 2 diabetes, weight management and sleep apnoea with obesity.

Brand names

How it works

Tirzepatide acts on two hormone receptors, GIP and GLP-1, released after eating. Together they boost insulin when blood sugar is high, lower glucagon, slow stomach emptying and reduce appetite. Acting on both receptors is thought to explain its larger effect on weight.

Used for

Side effects

How often, from the official product information. Bold = serious.

Very common more than 1 in 10

  • Nausea
  • Diarrhoea
  • Vomiting, constipation and tummy pain, especially at weight-loss doses
  • Less appetite
  • Low blood sugar, if also on insulin or a sulfonylurea

Common 1 in 10 to 1 in 100

  • Allergic reactions such as rash or itch
  • Dizziness
  • Low blood pressure
  • Indigestion, reflux, burping, wind or bloating
  • Gallstones or gallbladder inflammation
  • Hair thinning
  • Injection-site reactions
  • Tiredness
  • Faster heart rate
  • Raised pancreatic enzymes on blood tests

Uncommon 1 in 100 to 1 in 1,000

  • Pancreatitis (inflamed pancreas)
  • Slower stomach emptying
  • Altered taste or unusual skin sensations
  • Injection-site pain

Rare 1 in 1,000 to 1 in 10,000

  • Anaphylaxis (severe allergic reaction)
  • Angioedema (swelling of the face, lips or throat)

Get help urgently if

Good to know

Information only. Not a recommendation or endorsement of any product. Whether a medicine suits you depends on your health and other medicines, so talk to your doctor or pharmacist. In an emergency, call 000.

More information

Reviewed October 2026.